- Adrian Mindel,
- Melinda Tenant-Flowers
Introduction
Infection with HIV causes a spectrum of clinical problems beginning at the time of seroconversion (primary HIV) and terminating with AIDS and death. It is now recognised that it may take 10 years or more for AIDS to develop after seroconversion. The Centers for Disease Control (CDC) in the USA developed the most widely used classification for HIV disease based on the presence of clinical symptoms and signs, the presence of certain conditions and investigative findings, the availability of HIV screening and the degree of immunosuppression as measured by the CD4 lymphocyte count. The infection is divided into four groups:
This article has been adapted from the forthcoming 5th edition of ABC of AIDS. The book will be available from the BMJ bookshop and at www.bmjbooks.com
Summary of CDC 1992 classification system for HIV disease
Group I Primary HIV
Group II Asymptomatic infection
Group III Persistent generalised lymphadenopathy
Group IV Symptomatic infection
Group IVA HIV wasting syndrome (AIDS) and constitutional disease
Group IVB HIV encephalopathy (AIDS) and neurological disease
Group IVC1 Major opportunistic infections specified as AIDS defining
Group IVC2 Minor opportunistic infections
Group IVD Cancers specified as AIDS defining
Group IVE Other conditions
Group I Primary HIV infection
Group II Asymptomatic phase
Group III Persistent generalised lymphadenopathy
Group IV Symptomatic infection
Group IV is subdivided into several subgroups and some of these (groups IVA, B, C1 and D) are AIDS defining conditions.
In 1992 the CDC included all HIV infected persons with CD4 lymphocyte counts of <200×106 cells/l as fulfilling an AIDS defining diagnosis. However, this additional classification is not widely used outside the USA.
A second classification also combines clinical and CD4 count information. Symptoms and clinical findings are graded in severity from A to C and CD4 counts as they fall from 1 to 3.
Group I Primary HIV infection
Primary HIV infection (PHI) is also called the seroconversion …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Assaulting alternative medicine: worthwhile or witch hunt?
Published 17 February 2012
Re: Telemedicine doctors abroad don’t have to register with the GMC
Published 17 February 2012
Re: Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries
Published 17 February 2012
Consumer panic due to wheat anaphylaxis triggered by a skincare product in Japan
Published 17 February 2012
Re: Urinary incontinence after treatment for prostate cancer
Published 17 February 2012
Most responses
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012
Newer antidepressants for the treatment of depression in adults (5 responses)
Published 19 Jan 2012